trending Market Intelligence /marketintelligence/en/news-insights/trending/zfvjoeximagvghkotqdrig2 content esgSubNav
In This List

Spring Bank Pharmaceuticals plans common stock offering

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Spring Bank Pharmaceuticals plans common stock offering

Spring Bank Pharmaceuticals Inc. is planning to undertake an underwritten public offering of its common stock.

The Hopkinton, Mass.-based biopharmaceutical company intends to grant the underwriters an option to buy up to an additional 15% of shares offered.

Spring Bank intends to use the net proceeds for funding clinical trials, nonclinical studies, research and development and for general corporate purposes.

Jefferies LLC and Piper Jaffray & Co. are acting as joint book-running managers for the proposed offering.